HopeStage
Back to all studies
TerminatedNCT02435095

Antipsychotic Induced Structural and Functional Brain Changes

Medication studyAges 18–65GermanySchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Aachen and 10 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateMay 2015
Recruitment status
Terminated
Enrollment listed in the registry
174
Sponsor
RWTH Aachen University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
From 18 Years to 65 Years
Official registry ID
NCT02435095
Official title
Show the full official title

Are Antipsychotics Neurotoxic or Neuroprotective? A Long-term Comparison of Two Treatment Strategies

Recruitment & locations

Terminated

Aachen · Bonn · Düren

6 more locations
  • Düsseldorf
  • Essen
  • Gangelt
  • Krefeld
  • Langenfeld
  • Viersen

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is RWTH Aachen University, a university.

Does this study involve medication?

Yes. The study involves medication, including Maintenance treatment and Intermittent treatment.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies